查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600445

抗苗勒管激素测试市场：按产品、最终用户、分销、应用 - 全球预测 2025-2030

Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗苗勒氏管激素检测市值为27426万美元，预计2024年将达到30541万美元，复合年增长率为11.46%，到2030年将达到58648万美元。

抗苗勒氏管激素 (AMH) 测试可测量血液中的 AMH 水平，并为卵巢储备、生育能力和生育治疗计划提供重要见解。 AMH 检测的需求源自于不孕症评估、闭经预测、卵巢症候群 (PCOS) 诊断以及癌症治疗期间卵巢功能评估的应用。最终用途范围主要包括生育诊所、实验室、医院和诊断中心。不孕症盛行率的上升、生殖医学意识的提高以及检测技术的进步正在推动市场的成长。新的机会出现在个人化医疗以及将 AMH 检测纳入更广泛的生育治疗计划中。 AMH检测的应用也可能扩大到男性内分泌学和儿科内分泌学。主要建议包括投资于技术进步，例如就地检验套件，以提高可及性和准确性，并探索与生育诊所建立合作伙伴关係以寻求全面解决方案。

主要市场统计
基准年[2023] 27426万美元
预测年份 [2024] 30541万美元
预测年份 [2030] 5.8648亿美元
复合年增长率（%） 11.46%

影响市场开拓的限制包括测试成本高、新兴市场认知度低以及测试解释的变异性。此外，围绕不孕症治疗的伦理问题和监管挑战也可能阻碍市场进步。为了应对这些问题，有针对性的宣传活动和津贴测试方案可能会有所帮助。创新可以集中于开发具有成本效益的测试，以快速提供结果，并利用人工智慧在生殖医学中进行更好的预测分析。此外，对 AMH 广泛适用性（包括其在各种疾病状态中的作用）的生物技术研究可能会开闢新的途径。市场的性质表明竞争格局存在地区差异，北美和欧洲占主导地位，但亚太地区拥有巨大的开拓潜力。市场相关人员正在探索策略伙伴关係，以提高市场渗透率并满足这些新兴地区的需求，同时平衡不孕症诊断的方面和社会文化方面，并鼓励投资于教育措施。

市场动态：揭示快速发展的抗苗勒氏管激素测试市场的关键市场洞察

供需的动态交互作用正在改变抗苗勒氏管激素检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球卵巢症候群盛行率不断上升
    • 体外受精及卵子冷冻手术数量增加
  • 市场限制因素
    • AMH 测试的报销限额
  • 市场机会
    • 抗苗勒氏管激素检测技术的进展
    • 政府提高生殖和不孕不育健康意识的倡议
  • 市场问题
    • 与抗苗勒氏管激素检测套组相关的矛盾和错误结果

波特五力：驾驭抗苗勒氏管激素测试市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解抗苗勒氏管激素检测市场的外部影响

外部宏观环境因素在塑造抗缪勒氏管激素测试市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解抗苗勒氏管激素检测市场的竞争格局

抗苗勒管激素测试市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：抗苗勒氏管激素测试市场供应商的绩效评估

FPNV 定位矩阵是评估抗苗勒管激素测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

该报告提供了涵盖关键焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的广泛资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球多卵巢症候群盛行率上升
      • 体外受精和卵子冷冻手术的增加
    • 抑制因素
      • AMH 测试的退款是有限的。
    • 机会
      • 抗苗勒氏管激素检测技术的进展
      • 政府采取措施提高人们对生殖和不孕症健康的认识
    • 任务
      • 与抗穆氏管荷尔蒙套件相关的不一致和不正确的结果
  • 市场区隔分析
    • 产品：消费者对POC测试以获得专家监督的偏好正在增加
    • 最终用户：AMH检测套组在商业实验室中越来越受欢迎，可提供准确、快速的结果
    • 分销：提高 AMH检测套组在线上通路的可用性
    • 应用：AMH检测套组在人体应用的重要用途
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章抗苗勒氏管激素检测市场：分产品

  • 介绍
  • POC测试
  • 自检套件

第七章 抗苗勒氏管激素测试市场：依最终用户分类

  • 介绍
  • 商业实验室
  • 研究与开发

第八章抗苗勒氏管激素检测市场：依分布

  • 介绍
  • 线下通路
  • 线上通路

第九章抗苗勒氏管激素检测市场：依应用分类

  • 介绍
  • 人类
  • 非人类灵长类动物

第十章美洲抗苗勒氏管激素检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区抗苗勒氏管激素检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲抗苗勒氏管激素检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 西门子 Healthineers 采用新的卵巢储备评估方法
    • ARUP 实验室以 MenoCheck 彻底改变更年期管理
    • 推出 Elecsys抗穆氏管荷尔蒙加免疫检测，以提高可及性和早期检测
    • 使用 Fertilly 的创新家用不孕症测试进行抗穆氏管荷尔蒙分析，了解您的生殖健康状况
    • SD Biosensor 和 SJL Partners 对 Meridian Bioscience 的策略性收购增强了成长和全球影响力
    • Randox 品质控制推出先进的 Acusera AMH 控制来增强生殖测试

公司名单

  • Abbexa Limited
  • Abcam PLC
  • Ansh Labs LLC
  • Athenese-Dx
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux SA
  • BioVendor-Laboratorni Medicina AS
  • Chengdu VACURE BIoTechnology Co., Ltd.
  • CTK BIoTech, Inc.
  • Cusabio Technology LLC
  • Eagle Biosciences, Inc.
  • Elabscience Bionovation Inc.
  • Epitope Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Europe NV by HU Group Holdings, Inc.
  • Goldsite Diagnostics Inc.
  • Healthy Human Labs Limited（Vitall）
  • Kamiya Biomedical Company
  • LifeSpan BioSciences, Inc.
  • London Gynaecology Limited
  • Meridian Bioscience, Inc.
  • Monobind Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Vitrosens BIoTechnology Co., Ltd.
Product Code: MRR-BC3400CDF7AF

The Anti-Mullerian Hormone Test Market was valued at USD 274.26 million in 2023, expected to reach USD 305.41 million in 2024, and is projected to grow at a CAGR of 11.46%, to USD 586.48 million by 2030.

The Anti-Mullerian Hormone (AMH) Test measures the level of AMH in blood, offering vital insights into ovarian reserve, fertility potential, and planning fertility treatments. The necessity of AMH testing arises from its applications in fertility assessments, predicting menopause onset, diagnosing polycystic ovarian syndrome (PCOS), and evaluating ovarian function during cancer treatments. The end-use scope primarily includes fertility clinics, research laboratories, hospitals, and diagnostic centers. The rising prevalence of infertility, increasing awareness of reproductive health, and advancements in testing technologies drive the market growth. Emerging opportunities are seen in personalized medicine and the integration of AMH testing within broader fertility treatment plans. There is potential in expanding AMH test applications in male and pediatric endocrinology as well. Key recommendations include investing in technological advancements such as point-of-care testing kits to improve accessibility and accuracy, and exploring collaborations with fertility clinics for integrated solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 274.26 million
Estimated Year [2024] USD 305.41 million
Forecast Year [2030] USD 586.48 million
CAGR (%) 11.46%

Limitations affecting market growth include the high cost of testing, limited awareness in developing regions, and variability in test interpretation. Moreover, ethical concerns surrounding fertility treatments and regulatory challenges might hinder market progress. To counteract these, targeted awareness campaigns and subsidized testing options may prove beneficial. Innovations could focus on developing cost-effective testing methods that provide rapid results, or leveraging AI for better predictive analytics in reproductive health. Furthermore, biotechnological research into AMH's broader applicability, such as its role in various medical conditions, could open new avenues. The market nature suggests a competitive landscape with regional disparities in adoption rates, dominated by North America and Europe but with significant untapped potential in Asia-Pacific. Market players are encouraged to explore strategic partnerships and invest in educational initiatives to enhance market penetration and address demand in these emerging regions, balancing both the technical and socio-cultural facets of fertility diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Mullerian Hormone Test Market

The Anti-Mullerian Hormone Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of polycystic ovary syndrome worldwide
    • Growing number of IVF and egg-freezing procedures
  • Market Restraints
    • Limited reimbursements available for AMH tests
  • Market Opportunities
    • Advancements in anti-Mullerian hormone test technology
    • Government initiatives for creating awareness associated with reproductive and infertility treatment health
  • Market Challenges
    • Inconsistencies and false results associated with anti-Mullerian hormone kits

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Mullerian Hormone Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Mullerian Hormone Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Mullerian Hormone Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Mullerian Hormone Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Mullerian Hormone Test Market

A detailed market share analysis in the Anti-Mullerian Hormone Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Mullerian Hormone Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Mullerian Hormone Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Ansh Labs LLC, Athenese-Dx, Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux S.A., BioVendor - Laboratorni Medicina A.S., Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Eagle Biosciences, Inc., Elabscience Bionovation Inc., Epitope Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Fujirebio Europe N.V. by H.U. Group Holdings, Inc., Goldsite Diagnostics Inc., Healthy Human Labs Limited (Vitall), Kamiya Biomedical Company, LifeSpan BioSciences, Inc., London Gynaecology Limited, Meridian Bioscience, Inc., Monobind Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tosoh Corporation, and Vitrosens Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Anti-Mullerian Hormone Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across POC Testing and Self-check Kits.
  • Based on End-User, market is studied across Commercial Labs and Research & development.
  • Based on Distribution, market is studied across Offline Channels and Online Channels.
  • Based on Use, market is studied across Human and Non-Human Primate.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of polycystic ovary syndrome worldwide
      • 5.1.1.2. Growing number of IVF and egg-freezing procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Limited reimbursements available for AMH tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in anti-Mullerian hormone test technology
      • 5.1.3.2. Government initiatives for creating awareness associated with reproductive and infertility treatment health
    • 5.1.4. Challenges
      • 5.1.4.1. Inconsistencies and false results associated with anti-Mullerian hormone kits
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing consumer preference for POC testing to obtain professional oversight
    • 5.2.2. End-User: Rising penetration of AMH test kits in commercial labs for accurate and rapid results
    • 5.2.3. Distribution: Emerging availability of AMH testing kits on online channels
    • 5.2.4. Use: Significant usage of AMH testing kits for human applications
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anti-Mullerian Hormone Test Market, by Product

  • 6.1. Introduction
  • 6.2. POC Testing
  • 6.3. Self-check Kits

7. Anti-Mullerian Hormone Test Market, by End-User

  • 7.1. Introduction
  • 7.2. Commercial Labs
  • 7.3. Research & development

8. Anti-Mullerian Hormone Test Market, by Distribution

  • 8.1. Introduction
  • 8.2. Offline Channels
  • 8.3. Online Channels

9. Anti-Mullerian Hormone Test Market, by Use

  • 9.1. Introduction
  • 9.2. Human
  • 9.3. Non-Human Primate

10. Americas Anti-Mullerian Hormone Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-Mullerian Hormone Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Introduction of Novel Assay by Siemens Healthineers' for Assessing Ovarian Reserve
    • 13.3.2. The Introduction of MenoCheck by ARUP Laboratories to Revolutionizing Menopausal Management
    • 13.3.3. The Advent of the Elecsys Anti-Mullerian Hormone Plus immunoassay for Enhanced Accessibility and Early Detection
    • 13.3.4. Innovative At-Home Fertility Test by Fertilly for Understanding Reproductive Health through Anti-Mullerian Hormone Analysis
    • 13.3.5. Strategic Acquisition of Meridian Bioscience by SD Biosensor and SJL Partners for Enhanced Growth and Global Impact
    • 13.3.6. Randox Quality Control Introduces Advanced Acusera AMH Control for Enhanced Reproductive Testing

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abcam PLC
  • 3. Ansh Labs LLC
  • 4. Athenese-Dx
  • 5. Beckman Coulter, Inc. by Danaher Corporation
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. bioMerieux S.A.
  • 9. BioVendor - Laboratorni Medicina A.S.
  • 10. Chengdu VACURE Biotechnology Co., Ltd.
  • 11. CTK Biotech, Inc.
  • 12. Cusabio Technology LLC
  • 13. Eagle Biosciences, Inc.
  • 14. Elabscience Bionovation Inc.
  • 15. Epitope Diagnostics, Inc.
  • 16. F. Hoffmann-La Roche Ltd.
  • 17. Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
  • 18. Goldsite Diagnostics Inc.
  • 19. Healthy Human Labs Limited (Vitall)
  • 20. Kamiya Biomedical Company
  • 21. LifeSpan BioSciences, Inc.
  • 22. London Gynaecology Limited
  • 23. Meridian Bioscience, Inc.
  • 24. Monobind Inc.
  • 25. Siemens Healthineers AG
  • 26. Thermo Fisher Scientific Inc.
  • 27. Tosoh Corporation
  • 28. Vitrosens Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 20. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 21. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 22. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 23. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 24. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 25. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 26. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 27. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 28. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 29. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 30. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 31. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 32. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 33. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 34. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 35. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 36. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 37. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 38. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 39. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 40. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 41. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 42. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 43. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 44. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 45. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 46. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 47. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 48. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 49. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 50. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 51. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 52. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 53. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 54. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 55. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 56. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 57. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 58. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 59. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 60. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 61. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 62. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 63. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 64. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 65. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 66. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 67. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 68. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 69. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 70. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 71. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 72. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 73. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 74. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 75. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 77. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 78. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 79. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 80. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 81. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 82. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 83. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 84. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 85. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 86. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 87. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 88. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 89. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 90. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 91. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 92. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 93. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 94. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 95. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 96. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 97. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 103. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 104. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 105. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 106. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 107. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 108. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 109. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 110. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 111. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 112. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 113. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 114. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 115. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 116. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 117. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 118. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 119. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 120. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 121. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 122. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 123. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 124. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 125. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 126. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 127. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 128. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 129. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 130. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 131. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 132. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 133. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 134. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 135. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 136. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 138. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 139. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 140. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 141. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 142. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 143. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 144. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 145. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 146. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 147. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 148. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 149. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 150. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 151. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 152. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 153. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 154. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 155. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 156. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 157. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 158. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 159. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 160. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 161. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 162. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 163. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 164. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 165. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 166. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 167. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 168. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 169. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 170. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 171. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 172. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 173. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 174. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 175. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 176. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 177. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 178. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 179. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 180. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 181. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 182. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 183. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 184. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 185. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 186. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 187. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023